TECLens, Inc., a clinical-stage ophthalmic medical device company, announced today the treatment of the initial patient for its first-in-human clinical trial evaluating the company's groundbreaking ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Ophthalmology is becoming data-driven, using advanced imaging to move beyond static ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results